Home » Development and Validation of a Corona CAD Method for Simultaneous Determination of Peptides, Lipids and Lipid-Impurities in the Synthetic Pulmonary Surfactant Formulation Surfaxin

Development and Validation of a Corona CAD Method for Simultaneous Determination of Peptides, Lipids and Lipid-Impurities in the Synthetic Pulmonary Surfactant Formulation Surfaxin

http://www.accelacomm.com/jlp/source/32/50211273/?

More content on this topic:

  • Featured White Papers